Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis

NCT02799472 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: GSK3196165
DRUG: Placebo
DRUG: MTX
DRUG: Folic (or folinic) acid

Sponsor

GlaxoSmithKline

Collaborators

[object Object]